No images? Click here
In this edition:
- Investing in Human & Planetary Evolution: Announcing Arvind Gupta as our New Partner
- Endpoint Health: Partnering with Founders Building the Precision Medicine Platform to Save Millions of Lives
- Mammoth Biosciences: Exclusive License for CasPhi Proteins, COVID-19 Test Gets NIH Funding
- Mission Bio: Announcing $70M Series C Funding to Accelerate Development of Cancer Therapies
- Qventus: Helping Hospitals Address Near-term COVID-19 Challenges and Create Long-term Operational Efficiencies
- Innovator Spotlight: Geltor Co-founder & CEO Alex Lorestani on Building Engineering Biology Companies
Investing in Human & Planetary Evolution: Announcing Arvind Gupta as our New Partner
To support human and planetary evolution, we need to adapt as an industry to become conscious capitalists, building business for better rather than for business as usual. We’re thrilled to have Arvind Gupta on board as we expand our Engineering Biology investment practice.
Endpoint Health: Partnering with Founders Building the Precision Medicine Platform to Save Millions of Lives
Congratulations to Jason Springs, Diego Rey, Leonardo Teixeira, Jeff Osborn and the entire Endpoint Health team, which recently launched with a precision medicine platform for acute care to save millions of lives. Welcome to the Mayfield family!
Mammoth Biosciences: Exclusive License for CasPhi Proteins, COVID-19 Test Gets NIH Funding
Mammoth Biosciences continues to lead CRISPR innovation, with an exclusive license on new CRISPR proteins, an NIH contract for their COVID-19 test, and their partnership with GSK on a consumer COVID-19 test.
Mission Bio: Announcing $70M Series C Funding to Accelerate Development of Cancer Therapies
Our journey with Mission Bio began in 2017 when we led their $10M Series A, prior to them even having a product. Raising capital from top-tier investor Novo Holdings is a testament to the progress the team has made in realizing their vision - to enable a better understanding of cancer in order to develop and deliver precision treatments.
Qventus: Helping Hospitals Address Near-term COVID-19 Challenges and Create Long-term Operational Efficiencies
AI-based healthcare operations platform Qventus has delivered significant operational efficiency to hospitals and launched an innovative COVID-19 utilization tracker.
Innovator Spotlight: Geltor Co-founder & CEO Alex Lorestani on Building Engineering Biology Companies
Designer protein platform Geltor recently raised nearly $100M in their Series B - in this podcast, Co-founder & CEO Alex Lorestani sits down with Arvind Gupta to share their journey and the evolution of engineering biology as a space.
